Moreover, IGF2BP3 promoted both the proliferation and cisplatin resistance of bladder cancer cells by binding to the 5'- UTR region of CDK6 mRNA and enhancing its stability in an m6A-dependent manner. The gene discussed is CDK6; the disease is urinary bladder carcinoma.